157
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile

, &
Pages 1887-1893 | Received 13 Jan 2016, Accepted 17 Apr 2016, Published online: 10 May 2016

References

  • Fang JM, Fowler PA, Sayers C, Williams PA. The chemical modification of a range of starches under aqueous reaction conditions. Carbohydr Polym 2004;55:283–9.
  • Svensson E, Eliasson A-C. Crystalline changes in native wheat and potato starches at intermediate water levels during gelatinization. Carbohydr Polym 1995;26:171–6.
  • Rajan A, Prasad VS, Emilia Abraham T. Enzymatic esterification of starch using recovered coconut oil. Int J Biol Macromol 2006;39:265–72.
  • Brouillet F, Bataille B, Cartilier L. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation. Int J Pharm 2008;356:52–60.
  • Nabais T, Brouillet F, Kyriacos S, et al. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2007;65:371–8.
  • Brouillet F, Baylac G, Cartilier L, Bataille B. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process. Drug Dev Ind Pharm 2010;36:795–805.
  • Nabais T, Leclair G. High-amylose sodium carboxymethyl starch matrices: development and characterization of tramadol hydrochloride sustained-release tablets for oral administration. ISRN Pharm 2014;2014. doi:10.1155/2014/391523.
  • Cartilier L, Ungur M, Chebli C. Tablet formulation for sustained drug-release. Canadian Patent Application No. 2,491,665, December 24, 2004; PCT Application No. PCT/CA2005/001934, December 20.
  • Ungur M, Yonis N, Chebli C, Cartilier L. The evaluation of carboxymethylamylose for oral drug delivery systems: from laboratory to pilot scale. In: Book of abstracts of the 3rd international symposium on advanced biomaterials/biomechanics (ISAB2). Montreal, Canada; 2005:271.
  • Cao QR, Choi YW, Cui JH, Lee BJ. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. J Control Release 2005;108:351–61.
  • Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet 2004;43:879–923.
  • Ferey-Roux G, Perrier J, Forest E, et al. The human pancreatic alpha-amylase isoforms: isolation, structural studies and kinetics of inhibition by acarbose. Biochim Biophys Acta 1998;14:10–20.
  • Clem D, Maidment J, Ringham JM. A study into the measurement of alpha-amylase activity using phadebas, iodine and gel-diffusion procedures. Nut Food Sci 2001;31:141–6.
  • Chebli C, Cartilier L, Hartman NG. Substituted amylose as a matrix for sustained-drug release: a biodegradation study. Int J Pharm 2001;222:183–9.
  • Rahmouni M, Chouinard F, Nekka F, et al. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac. Eur J Pharm Biopharm 2001;51:191–8.
  • Dumoulin Y, Cartilier LH, Mateescu MA. Cross-linked amylose tablets containing α-amylase: an enzymatically-controlled drug release system. J Control Release 1999;60:161–7.
  • US Pharmacopeial Convention. Dissolution. In: United States Pharmacopeia 36/National Formulary 31. Rockville, MD: US Pharmacopeial Convention; 2013.
  • Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20:64–74.
  • Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm 1989;57:169–72.
  • Calinescu C, Mulhbacher J, Nadeau É, et al. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations. Eur J Pharm Biopharm 2005;60:53–60.
  • Colonna P, Buleon A, Lemarie F. Action of Bacillus subtilis alpha-amylase on native wheat starch. Biotechnol Bioeng 1988;31:895–904.
  • Gallant DJ, Bouchet B, Buleon A, Perez S. Physical characteristics of starch granules and susceptibility to enzymatic degradation. Eur J Clin Nutr 1992;46:S3–S16.
  • Leloup VM, Colonna P, Ring SG. Physico—chemical aspects of resistant starch. J Cereal Sci 1992;16:253–66.
  • Planchot V, Colonna P, Gallant DJ, Bouchet B. Extensive degradation of native starch granules by alpha-amylase from aspergillus fumigatus. J Cereal Sci 1995;21:163–71.
  • Leloup VM, Colonna P, Ring SG. Alpha-Amylase adsorption on starch crystallites. Biotechnol Bioeng 1991;38:127–34.
  • Braganza JM, Herman K, Hine P, et al. Pancreatic enzymes in human duodenal juice-a comparison of responses in secretin pancreozymin and Lundh Borgström tests. Gut 1978;19:358–66.
  • Chien YW. Fundamentals of controlled-release drug administration. In: Swarbrick J, ed. Novel drug delivery systems. New York: Marcel Dekker, Inc.; 1982:465–574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.